Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacological stimulation of marrow function.

J W Adamson

    Clinics in Haematology
    |October 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Pharmacological agents can stimulate marrow function and aid in rescuing damaged marrow after chemotherapy. However, enhancing function in idiopathic marrow failure remains challenging, requiring further research into underlying mechanisms.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The rate of marrow recovery and extent of donor engraftment following transplantation of ex vivo-expanded bone marrow cells are independently influenced by the cytokines used for expansion.

    Stem cells and development·2005
    Same author

    Murine bone marrow cells cultured ex vivo in the presence of multiple cytokine combinations lose radioprotective and long-term engraftment potential.

    Stem cells and development·2004
    Same author

    Placental/umbilical cord blood (PCB) stem cells for transplantation: early clinical outcomes and the status of ex vivo expansion strategies.

    The Keio journal of medicine·2001
    Same author

    Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity.

    Blood·2000
    Same author

    Identification of five new isoforms of murine thrombopoietin mRNA.

    Biochemical and biophysical research communications·2000
    Same author

    Identification of a glialblastoma cell differentiation factor-related gene mRNA in human microvascular endothelial cells.

    Genomics·2000
    Same journal

    Myelodysplastic syndromes.

    Clinics in haematology·1986
    Same journal

    In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.

    Clinics in haematology·1986
    Same journal

    Myelodysplastic syndromes: natural history and features of prognostic importance.

    Clinics in haematology·1986
    Same journal

    Pathogenesis and clinical variations in the myelodysplastic syndromes.

    Clinics in haematology·1986
    Same journal

    The treatment of myelodysplastic syndromes.

    Clinics in haematology·1986
    Same journal

    Secondary myelodysplastic syndromes and leukaemias.

    Clinics in haematology·1986
    See all related articles

    Area of Science:

    • Hematology
    • Pharmacology
    • Cell Biology

    Background:

    • Pharmacological stimulation studies offer insights into marrow cell proliferation.
    • Effects are clearest in normal or recovering marrow, influencing various progenitor cells.

    Purpose of the Study:

    • To explore the potential of pharmacological agents in modulating marrow function.
    • To assess the feasibility of enhancing marrow function in cases of marrow failure, particularly aplastic conditions.

    Main Methods:

    • Review of studies on pharmacological stimulation of marrow function.
    • Analysis of in vitro experiments involving marrow cell culturing with various agents.

    Main Results:

    • Multiple agents influence progenitor cell growth and cycle activity.

    Related Experiment Videos

  • Pharmacological approaches show promise for rescuing marrow post-chemotherapy.
  • Limited success in enhancing function for idiopathic marrow failure patients.

    • Conclusions:

    • Pharmacological stimulation is effective for 'rescuing' damaged marrow.
    • Significant enhancement of marrow function in aplastic patients is not yet feasible.
    • Further characterization of marrow growth patterns in failure is needed for targeted therapy.